POM
POMDOCTOR LIMITED American Depositary Shares
NASDAQ: POM · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.97
-5.15% today
Updated 2026-08-14
Market cap
$8.13M
P/E ratio
—
P/S ratio
0.06x
EPS (TTM)
$-6.01
Dividend yield
—
52W range
$0 – $6
Volume
0.4M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-33.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →220 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Revenue growth 17.20% QoQ
+ Debt/equity -1.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -33.39 — distress zone
- Thin margins at -53.20%
- Negative free cash flow $-149.49M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $245.22M | $304.85M | $342.56M | $399.91M | $399.92M |
| Net income | $-125.51M | $-145.39M | $-143.36M | $-212.58M | $-212.58M |
| EPS | — | — | — | — | $-6.01 |
| Free cash flow | $-22.02M | $-45.91M | $-16.17M | $-149.49M | $-149.49M |
| Profit margin | -51.18% | -47.69% | -41.85% | -53.16% | -53.20% |
Peer comparison
Smart narrative
POMDOCTOR LIMITED American Depositary Shares trades at $0.97. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -33.39, it sits in the distress. TTM revenue stands at $399.92M. with profit margins at -53.20%.
Frequently asked questions
What is POMDOCTOR LIMITED American Depositary Shares's stock price?
POMDOCTOR LIMITED American Depositary Shares (POM) trades at $0.97, on a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is POMDOCTOR LIMITED American Depositary Shares overvalued?
POMDOCTOR LIMITED American Depositary Shares carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is POMDOCTOR LIMITED American Depositary Shares's revenue?
POMDOCTOR LIMITED American Depositary Shares's trailing twelve-month revenue is $399.92M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
POMDOCTOR LIMITED American Depositary Shares's Altman Z-Score is -33.39, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryPHARMACEUTICAL RETAILERS
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.06x
ROE—
Beta—
50D MA$1.32
200D MA$17.79
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—